Next Up

Antibody Engineering: Online

27 - 29 June 2022 |

Online: BST (UTC+1)

27 - 29 June 2022

Online: BST (UTC+1)

A focused 3-day meeting that delves into emerging technologies in antibody-based molecular engineering, novel & difficult targets, antibody-based therapeutics & a meeting place for experts working within engineering, computational tools and biotherapeutics. 

23 Jun 2022
Thu, 23 June 2022

Bactericidal Antibody Response: Measuring Immunogenicity and Vaccine Efficacy

Presented by Nexelis

14 Sep 2022
Wed, 14 September 2022

Oligonucleotide Chemistry & Therapeutics Symposium

An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics

10 Nov 2022
Thu, 10 November 2022

Upcoming Biologics Nexelis Webinar

Presented by Nexelis

Highlights

Vaccines Europe
Industry Spotlight
Discover key event highlights from Oxford Global's upcoming Vaccines Congress 2022.
Edited by Tia Byer |
24 June 2022
Vaccines
Discussion Group Report
Edited by Tia Byer |
24 Jun 2022
Peptides
Industry Spotlight
Edited by Tia Byer |
22 Jun 2022
Proteins & Antibodies

In-Depth

Discussion Group Report
Nazneen Dewji, President and CEO of Cenna Biosciences leads a discussion on the strategies to overcome the challenges ‘Oral Delivery of Peptides’.
24 June 2022
Insight Article
Key opinion leaders share their thoughts on the prospect of effector cell redirection and cell engagers at Biologics UK: In-Person 2022.
07 June 2022
Commentary
In this Commentary article, we explore how innovative technologies like expression tags could help to overcome challenges associated with recombinant peptide production. The potential for recombinant production to slash manufacturing costs has made it a focal area of research for companies such as Boehringer Ingelheim.
17 May 2022
Insight Article
UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.
10 May 2022

Industry Spotlight

Industry Spotlight
Discover key event highlights from Oxford Global's upcoming Vaccines Congress 2022.
24 June 2022
Industry Spotlight
Hot off the press, we look at this week’s breaking news stories from the Biologics industry.
22 June 2022
Industry Spotlight
Clinical studies testing treatments for severe COVID-19 face major delays due to eligibility issues.
17 June 2022
Industry Spotlight
The FDA gives the green light to GSK’s measles, mumps, and rubella vaccine, providing US clinicians with a new treatment option for childhood inoculation for first time in more than 50 years.
09 June 2022

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login